Blog

Gene therapy startup’s stock stumbles after FDA questions treatment

img0089900xx5184-3456-0-0

LogicBio Therapeutics had hoped to begin testing what could be the first gene-targeting treatment designed specifically for infants and children, but FDA qualms have put a moratorium on those plans.

Read More